{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:43:41Z","timestamp":1792079021019,"version":"4.4.0"},"reference-count":43,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T00:00:00Z","timestamp":1545177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010669","name":"H2020 LEIT Information and Communication Technologies","doi-asserted-by":"publisher","award":["2013M3A9D5072550"],"award-info":[{"award-number":["2013M3A9D5072550"]}],"id":[{"id":"10.13039\/100010669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010669","name":"H2020 LEIT Information and Communication Technologies","doi-asserted-by":"publisher","award":["2016R1E1A1A01941213"],"award-info":[{"award-number":["2016R1E1A1A01941213"]}],"id":[{"id":"10.13039\/100010669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2009-0093826"],"award-info":[{"award-number":["2009-0093826"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["faseb.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The FASEB Journal"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    The overactivity of cannabinoid 1 receptor (CB1R) is associated with obesity and type 2 diabetes. First\u2010generation CB1R antagonists, such as rimonabant, offered therapeutic advantages for the control of obesity and related metabolic abnormalities, but their therapeutic potential was limited by undesirable neuropsychiatrie side effects. Here, we evaluated AJ5012 as a novel potent peripheral CB1R antagonist and, using this antagonist, investigated the role of peripheral CB1R on adipose tissue inflammation in obese mouse models. AJ5012 had a high degree of CB1R and cannabinoid 2 receptor selectivity but a low brain:plasma concentration ratio without eliciting centrally mediated neurobehavioral effects. In diet\u2010induced obese (DIO) mice, AJ5012 did not reduce food intake but did induce a significant weight loss, likely owing to an increased energy expenditure. It was as effective as rimonabant for the improvement of hormonal or metabolic abnormalities, glycemic control, and insulin sensitivity. The treatment of DIO and leptin receptor\u2013deficient mice with AJ5012 also exhibited effects comparable to rimonabant for the prevention of macrophage infiltration, activation of the nucleotide\u2010binding domain and leucine\u2010rich repeat protein 3 inflammasome, and production of proinflammatory cytokines, which resulted in the suppression of adipose tissue inflammation. In addition to macrophage, activation of CB1R in 3T3\u2010L1 adipocytes induced the expression of proinflammatory genes, which was fully inhibited by AJ5012. Our findings identified AJ5012 as a novel peripheral CB1R antagonist and suggest that peripheral CB1R blockade might break the links between insulin resistance and adipose tissue inflammation.\u2014Han, J. H., Shin, H., Park, J.\u2010Y., Rho, J. G., Son, D. H., Kim, K. W., Seong, J. K., Yoon, S.\u2010H., Kim, W. A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice. FASEB J. 33, 4314\u20134326 (2019).\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.fasebj.org\">www.fasebj.org<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.1096\/fj.201801152rr","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T16:39:15Z","timestamp":1545237555000},"page":"4314-4326","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A novel peripheral cannabinoid 1 receptor antagonist, AJ5012, improves metabolic outcomes and suppresses adipose tissue inflammation in obese mice"],"prefix":"10.1096","volume":"33","author":[{"given":"Ji Hye","family":"Han","sequence":"first","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanho","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Gi","family":"Rho","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hwee","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Oral Biology Yonsei University College of Dentistry  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Woo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Oral Biology Yonsei University College of Dentistry  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Je Kyung","family":"Seong","sequence":"additional","affiliation":[{"name":"Laboratory of Developmental Biology and Genomics Research Institute for Veterinary Science College of Veterinary Medicine  Seoul South Korea"},{"name":"Korea Mouse Phenotyping Center (KMPC) Seoul National University  Seoul South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hwa","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wook","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology Ajou University  Suwon South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,12,19]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0009"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2009.04.004"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/db10-1550"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.2"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24733"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1240-4"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.01.032"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00545.2002"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1482"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044537"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2007.11.012"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66374-X"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0386"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2775"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00213-009-1506-7","article-title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","volume":"205","author":"Le Foil B.","year":"2009","journal-title":"Psychopharmacobgy (Berl.)"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2009.197"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/db08-0161"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-21-09612.2002"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00908.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42551"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2012.07.002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.06.066"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.08.011"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3265"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1199"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm980363y"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2015.02.044"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2018.04.006"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2012.01.016"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2002519"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, Central Nervous System (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Chose A. K.","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.541"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13350"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2925"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.arr.2015.06.004","article-title":"Damage-associated molecular patterns and their pathological relevance in diabetes mellitus","volume":"24","author":"Shin J. J.","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.11.011"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100255108"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2228"},{"key":"e_1_2_8_40_1","first-page":"183","article-title":"QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II\u03b1","volume":"8","author":"Alam S.","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.12.018"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.04-3177fje"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.13-247643"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83626"}],"container-title":["The FASEB Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.201801152RR","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1096\/fj.201801152RR","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/pdf\/10.1096\/fj.201801152RR","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:50:48Z","timestamp":1761673848000},"score":1,"resource":{"primary":{"URL":"https:\/\/faseb.onlinelibrary.wiley.com\/doi\/10.1096\/fj.201801152RR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,19]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1096\/fj.201801152RR"],"URL":"https:\/\/doi.org\/10.1096\/fj.201801152rr","archive":["Portico"],"relation":{},"ISSN":["0892-6638","1530-6860"],"issn-type":[{"value":"0892-6638","type":"print"},{"value":"1530-6860","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,19]]},"assertion":[{"value":"2018-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-12-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}